Literature DB >> 31641937

Key Points to Consider When Evaluating Andexxa for Formulary Addition.

Harry Peled1, Nhu Quyen Dau2, Helen Lau3.   

Abstract

Year:  2020        PMID： 31641937     DOI： 10.1007/s12028-019-00866-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  1 in total

1.  SiPP (Stroke in Pregnancy and Postpartum): A prospective, observational, international, multicentre study on pathophysiological mechanisms, clinical profile, management and outcome of cerebrovascular diseases in pregnant and postpartum women.

Authors:  Svetlana Lorenzano; Christine Kremer; Aleksandra Pavlovic; Dejana R Jovanovic; Else Charlotte Sandset; Hanne Christensen; Cheryl Bushnell; Anita Arsovska; Nikola Sprigg; Christine Roffe; Petra Ijäs; Zuzana Gdovinova; Anne Alexandrov; Marialuisa Zedde; Rossana Tassi; Monica Acciaresi; Maria Lantz; Katharina Sunnerhagen; Marija Zarkov; Kirsi Rantanen; Fabienne Perren; Helle K Iversen; Christina Kruuse; Agnieszka Slowik; Paola Palazzo; Janika Korv; Annette Fromm; Arijana Lovrencic-Huzjan; Eleni Korompoki; Ana Catarina Fonseca; Seana L Gall; Freimuth Brunner; Valeria Caso; Simona Sacco
Journal:  Eur Stroke J       Date:  2019-12-06
  1 in total
  3 in total

Review 1.  Major publications in the critical care pharmacotherapy literature: 2019.

Authors:  Melanie Smith Condeni; Alyson T Basting; Patrick G Costello; Ashley DePriest; Evert A Eriksson; Heather Evans; Kristie Hertel; Andre L Holder; Alyssa N Kester; Kinsey R Kowalski; Carolyn Magee Bell; Barbara McLean; Michael Reichert; Melissa Santibañez; Patrick M Wieruszewski; Andrea Sikora Newsome
Journal:  J Crit Care       Date:  2020-12-27       Impact factor: 3.425

2.  Reply to "Key Points to Consider When Evaluating Andexxa for Formulary Addition".

Authors:  Charles E Mahan
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

3.  Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects.

Authors:  Jack Ansell; Sasha Bakhru; Bryan E Laulicht; Gregory Tracey; Stephen Villano; Daniel Freedman
Journal:  Eur Heart J       Date:  2022-03-07       Impact factor: 29.983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.